TargetMol

NMPA-Approved Drug Library

Product Code:
 
TAR-L4210
Product Group:
 
Compound Libraries
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
Dry ice
Storage:
 
-20°C
 

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-L4210-1mg1 mgEnquire
Additional shipping charges apply. Please contact us for a quote.
Quantity:
TAR-L4210-100uL100 uL x 10 mM (in DMSO)Enquire
Additional shipping charges apply. Please contact us for a quote.
Quantity:
TAR-L4210-250uL250 uL x 10 mM (in DMSO)Enquire
Additional shipping charges apply. Please contact us for a quote.
Quantity:
TAR-L4210-30uL30 uL x 10 mM (in DMSO)Enquire
Additional shipping charges apply. Please contact us for a quote.
Quantity:
TAR-L4210-50uL50 uL x 10 mM (in DMSO)Enquire
Additional shipping charges apply. Please contact us for a quote.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Austria.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Show All

Further Information

Library Type:
Approved / Repurposing
Number of Compounds:
1580
Short Description:

- A unique collection of 1580 NMPA-approved drugs, ideal for high-throughput screening (HTS) and high-content screening (HCS).
- All compounds are officially approved by the NMPA and accompanied by their corresponding NMPA approval numbers, making this library a powerful tool for drug repurposing and novel target identification.
- Each compound has undergone rigorous preclinical studies and clinical trials, ensuring well-established biological activity and safety.
- Spans multiple therapeutic areas, including oncology, cardiovascular diseases, anti-inflammatory agents, immunomodulators, central nervous system (CNS) drugs, respiratory therapeutics, and more.
- Features structurally diverse compounds with potent pharmacological activity and excellent cell permeability.
- Comprehensive documentation provided for each compound, including chemical structure, target information, IC50 values, and detailed activity descriptions.
- Compound identity and high purity are verified using multiple analytical techniques - including NMR, HPLC/LCMS - minimizing the risk of false positives.